Scientific publications

Find all our publications, as well as the 17 papers selected by international scientific and medical congresses since June 2016.

21.09.2020

TOTUM•63: a new promising approach for the management of obesity and risk reduction for developing Type 2 Diabetes

View

21.09.2020

TOTUM•63 reduces body weight and improves insulin sensitivity in obese mice through pleiotropic effects on various metabolic organs

View

21.09.2020

TOTUM•63 lowers fasting glycemic in subjects with prediabetes: a Phase II clinical trial

View

12.06.2020

American Diabetes Association 2020 – 80th scientific sessions -TOTUM•63 lowers fasting glycemia in subjects with prediabetes: a phase II clinical trial

View

16.09.2019

European Association for the Study of Diabetes (EASD) annual congress 2019 – TOTUM•63 corrects levels of hormones associated to type 2 diabetes.

View

07.06.2019

American Diabetes Association 2019 – 79th scientific sessions – TOTUM•63 lowers adipose tissue inflammation

View

12.11.2018

American Association for the Study of Liver Diseases (AASLD), 2018 Congress – TOTUM•63 reduces hepatic steatosis

View

04.10.2018

European Association for the Study of Diabetes (EASD), 2018 Congress, Berlin (Germany) – TOTUM•63 multi-target mode of action

View

06.03.2018

Keystone Symposia 2018, Banff (Canada) – LpD64 reduces intestinal dysbiosis associated with metabolic disorders

View

22.01.2018

Keystone Symposia 2018, Keystone (USA) – TOTUM•63 acts on intestinal microbiota

View

04.12.2018

International Diabetes Federation, 2017 Congress, Abu Dhabi (UAE) – TOTUM•63 reduces hepatic steatosis

View

15.10.2017

Cell Symposium 2017, San Diego (USA) – LpD64, in vivo effects on lipids metabolism

View

09.06.2017

American Diabetes Association, 2017 Congress, San Diego (USA) – TOTUM•63, results of the Phase I/II clinical study

View

02.02.2017

Société Francophone du Diabète, 2017 Congress, Lille (France) – TOTUM•63, preclinical data on insulin resistance and fat mass

Voir

06.03.2017

American Diabetes Association, 2016 Congress, New Orleans (USA) – TOTUM•63, preclinical data on glucose metabolism

View

10.06.2016

Keystone Symposia 2016, Keystone (USA) – LpD64, preclinical data on obesity

View